<main class="detailed-guide" lang="en" role="main">
      



<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-l">
    Medicines: apply for a parallel import licence
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
        <p class="gem-c-lead-paragraph">How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application. </p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata govuk-!-margin-bottom-3" data-module="gem-toggle metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">21 January 2015</dd>
      <dt class="gem-c-metadata__term">Last updated</dt>
      <dd class="gem-c-metadata__definition">
        17 August 2022
          — <a class="gem-c-metadata__definition-link govuk-!-display-none-print js-see-all-updates-link" data-track-action="see-all-updates-link-clicked" data-track-category="content-history" data-track-label="history" href="#full-publication-update-history">
            See all updates
          </a>
      </dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>

<div class="govuk-!-display-none-print govuk-!-margin-bottom-6" data-module="gem-track-click">
  <form action="/email/subscriptions/single-page/new" class="gem-c-single-page-notification-button" data-button-location="top" data-track-action="Subscribe-button-top" data-track-category="Single-page-notification-button" data-track-label="/guidance/medicines-apply-for-a-parallel-import-licence" method="POST">
    <input name="base_path" type="hidden" value="/guidance/medicines-apply-for-a-parallel-import-licence">
    <button class="govuk-body-s gem-c-single-page-notification-button__submit" type="submit">  <svg class="gem-c-single-page-notification-button__icon" height="18" viewBox="0 0 459.334 459.334" width="18" xmlns="http://www.w3.org/2000/svg"><path d="M177.216 404.514c-.001.12-.009.239-.009.359 0 30.078 24.383 54.461 54.461 54.461s54.461-24.383 54.461-54.461c0-.12-.008-.239-.009-.359H175.216zM403.549 336.438l-49.015-72.002v-89.83c0-60.581-43.144-111.079-100.381-122.459V24.485C254.152 10.963 243.19 0 229.667 0s-24.485 10.963-24.485 24.485v27.663c-57.237 11.381-100.381 61.879-100.381 122.459v89.83l-49.015 72.002a24.76 24.76 0 0 0 20.468 38.693H383.08a24.761 24.761 0 0 0 20.469-38.694z" fill="currentColor"></path></svg>Get emails about this page
</button>
</form>
</div>





<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    


      <div class="app-c-contents-list-with-body" data-module="sticky-element-container">
      <div class="responsive-bottom-margin">
          <nav aria-label="Contents" class="gem-c-contents-list" data-module="gem-track-click" role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 1" data-track-category="contentsClicked" data-track-label="#parallel-import-licence-application-categories" data-track-options="{&quot;dimension29&quot;:&quot;Parallel import licence application categories&quot;}" href="#parallel-import-licence-application-categories">Parallel import licence application categories</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-label="#labels-patient-information-leaflets-and-packaging" data-track-options="{&quot;dimension29&quot;:&quot;Labels, patient information leaflets and packaging&quot;}" href="#labels-patient-information-leaflets-and-packaging">Labels, patient information leaflets and packaging</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#company-functions-involved-in-parallel-importing" data-track-options="{&quot;dimension29&quot;:&quot;Company functions involved in parallel importing&quot;}" href="#company-functions-involved-in-parallel-importing">Company functions involved in parallel importing</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 4" data-track-category="contentsClicked" data-track-label="#submit-your-parallel-import-licence-application" data-track-options="{&quot;dimension29&quot;:&quot;Submit your parallel import licence application&quot;}" href="#submit-your-parallel-import-licence-application">Submit your parallel import licence application</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 5" data-track-category="contentsClicked" data-track-label="#documents-for-submission" data-track-options="{&quot;dimension29&quot;:&quot;Documents for submission&quot;}" href="#documents-for-submission">Documents for submission</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 6" data-track-category="contentsClicked" data-track-label="#make-a-variation-to-your-parallel-import-licence" data-track-options="{&quot;dimension29&quot;:&quot;Make a variation to your parallel import licence&quot;}" href="#make-a-variation-to-your-parallel-import-licence">Make a variation to your parallel import licence</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 7" data-track-category="contentsClicked" data-track-label="#renew-your-parallel-import-licence" data-track-options="{&quot;dimension29&quot;:&quot;Renew your parallel import licence&quot;}" href="#renew-your-parallel-import-licence">Renew your parallel import licence</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 8" data-track-category="contentsClicked" data-track-label="#inspections-of-parallel-import-companies" data-track-options="{&quot;dimension29&quot;:&quot;Inspections of parallel import companies&quot;}" href="#inspections-of-parallel-import-companies">Inspections of parallel import companies</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 9" data-track-category="contentsClicked" data-track-label="#fees" data-track-options="{&quot;dimension29&quot;:&quot;Fees&quot;}" href="#fees">Fees</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--dashed">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 10" data-track-category="contentsClicked" data-track-label="#contact" data-track-options="{&quot;dimension29&quot;:&quot;Contact&quot;}" href="#contact">Contact</a>

        </li>
    </ol>
</nav>
      </div>
    
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>

        
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
          <div class="govspeak">
<p>The UK parallel import licensing scheme lets a medicine authorised in European Economic Area (<abbr title="European Economic Area">EEA</abbr>) Member State be marketed in the UK, as long as the imported product has no therapeutic difference from the cross-referenced UK product.</p>

<p>If you want to parallel import a product you must make sure that:</p>

<ul>
  <li>the product is manufactured to <a class="govuk-link" href="https://www.gov.uk/guidance/good-manufacturing-practice-and-good-distribution-practice">good manufacturing practice (<abbr title="good manufacturing practice">GMP</abbr>) standards</a>
</li>
  <li>you hold a <a class="govuk-link" href="https://www.gov.uk/guidance/apply-for-manufacturer-or-wholesaler-of-medicines-licences">wholesale dealer’s licence</a> covering importing, storage and sale for each product</li>
  <li>you hold the correct parallel import licence</li>
</ul>

<p>To assemble and repackage the product you will also need to have an <a class="govuk-link" href="https://www.gov.uk/guidance/apply-for-manufacturer-or-wholesaler-of-medicines-licences">manufacturer’s licence</a>covering product assembly.</p>

<p>If your product is controlled by the Misuse of Drugs Act you will need an import licence from the <a class="govuk-link" href="https://www.gov.uk/controlled-drugs-licences-fees-and-returns">Home Office</a>.</p>

<p>If you are granted a licence, you will still need to comply with any other statutory provisions or any private civil rights of third parties.</p>

<p>You must be entitled to use the name of your product and it must not infringe on trademarks. <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> does not consider trademark infringements when granting parallel import (<abbr title="parallel import">PLPI</abbr>) licences.</p>

<p>The normal requirements for <a class="govuk-link" href="https://www.gov.uk/guidance/send-and-receive-information-on-adverse-drug-reactions-adrs">reporting adverse reactions and defects</a> apply to <abbr title="parallel import">PLPI</abbr> products.</p>

<p>If a <abbr title="parallel import">PLPI</abbr> product needs to be recalled you must arrange this. The records you keep must be suitable for this, and you must notify <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> immediately and give the reason if you decide to withdraw a product.</p>

<p>To notify <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> you should call 020 3080 6574 or use the <a class="govuk-link" href="https://yellowcard.mhra.gov.uk/defective-products/" rel="external">defective product form on the Yellow Card website</a>.</p>

<h2>Parallel import licence application categories</h2>

<p><abbr title="parallel import">PLPI</abbr> applications fall into 3 categories.</p>

<h3>Parallel import (simple)</h3>

<p>A simple parallel import licence can be granted when:</p>

<ul>
  <li>the holder of the UK marketing authorisation and the holder of the marketing authorisation for the product to be imported from a Member State are held by companies in the same group; or</li>
  <li>a licensing agreement exists between the market authorisation holders</li>
</ul>

<p>This is the traditional ‘common origin’ criterion for parallel import licences.</p>

<h3>Parallel import (complex)</h3>

<p>This category applies when the UK and imported products do not share a common origin (as defined above) and:</p>

<ul>
  <li>the imported product contains a new excipient</li>
  <li>the imported product contains an active ingredient made by a different route from the UK product</li>
  <li>the imported product is a controlled release preparation</li>
  <li>the imported product is a sterile product which is sterilised in a different way from the UK product</li>
  <li>the imported product is a sterile product in which the container is made from a different material to the container of the UK product</li>
  <li>the imported product is an influenza vaccine</li>
  <li>the product is a metered dose inhaler</li>
  <li>the product is a powder for inhalation</li>
</ul>

<h3>Parallel import (standard)</h3>

<p>This category applies when the UK and imported products do not share a common origin (as defined above) but the application is not considered to be complex.</p>

<h2>Labels, patient information leaflets and packaging</h2>

<p>All labels, patient information leaflets (<abbr title="[patient information leaflets">PILs</abbr>) and packaging for parallel import medicines must comply with current guidance. Please see our guidance on <a class="govuk-link" href="https://www.gov.uk/guidance/medicines-packaging-labelling-and-patient-information-leaflets">submitting applications for labels, patient information leaflets (<abbr title="[patient information leaflets">PILs</abbr>) and packaging</a> for more information, although not all is relevant for parallel imports. You should email <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> Customer Services at <a class="govuk-link" href="mailto:MHRACustomerServices@mhra.gov.uk">MHRACustomerServices@mhra.gov.uk</a> if you need more information.</p>

<p>All excipients in parenteral, ophthalmic and topical medicinal products must appear on the labelling.</p>

<p>For all other medicines, only excipients of known effect should be declared on the labelling.</p>

<p><a class="govuk-link" href="http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003412.pdf" rel="external">European Medicine Agency guidelines</a> give the wording for the patient information leaflet and packaging for these excipients. These warnings must be included even if they weren’t present on the UK packing and PIL.</p>

<h3>User testing patient information leaflets</h3>

<p><abbr title="[patient information leaflets">PILs</abbr> must be user tested. <abbr title="parallel import">PLPI</abbr> companies can do their own user testing before the UK PIL has been user tested, as long as the tests show that users can find and understand the key messages in the leaflet.</p>

<p>However, if there are significant changes following user testing of the UK PIL, more testing may be necessary for the parallel import PIL to bring it in line with the UK version.</p>

<p>See <span class="attachment-inline"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/808259/User_Testing_Guidance_on_Patient_Information_Leaflets_for_Parallel_Importers.pdf">guidance on user testing information leaflets for parallel imported licences</a> (<span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">276 KB</span>, <span class="page-length" lang="en">10 pages</span>)</span></p>

<h2>Company functions involved in parallel importing</h2>

<p>Your application must inform <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> of which companies will be carrying out each function associated with import of a product by either putting them on the application form or attaching a list covering all the sites with their relevant manufacturer/importer or wholesale dealer licence numbers.</p>

<p>For all function sites outside the UK and within the <abbr title="European Economic Area">EEA</abbr> member states, <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> need proof that the site holds the relevant licence from the regulatory authority in that country.</p>

<h3>Suppliers’ list declaration</h3>

<p>You do not need to send a list of suppliers you will obtain the product from if you electronically submit the statement below. The statement, on letter-headed paper, should be signed and emailed as a PDF to <a class="govuk-link" href="mailto:plpi@mhra.gov.uk">plpi@mhra.gov.uk</a> and include this wording:</p>

<p>I confirm that (insert company name) (<abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> company number) (insert company number) will only obtain parallel import products from suppliers which hold an appropriate authorisation (wholesaler or manufacturer licence).</p>

<p>I confirm that the validity of this authorisation has been confirmed by us.</p>

<p>I confirm that the suppliers’ details will be recorded in the details of each batch of product imported.</p>

<p>Signed: Director</p>

<p>Name:</p>

<p>Date:</p>

<h2>Submit your parallel import licence application</h2>

<p>You should submit the application (<span class="attachment-inline"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/391637/PLPI_submission_document_requirements.pdf"><abbr title="parallel import">PLPI</abbr> submission document requirements</a> (<span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">146 KB</span>, <span class="page-length" lang="en">13 pages</span>)</span>) through the <a class="govuk-link" href="https://www.gov.uk/guidance/mhra-portal-register-to-submit-forms"><abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> portal</a>. The application form is available from the Portal.</p>

<p>Any submission that does not meet the submission requirements will be invalidated and rejected. You will be told the reasons for the invalidation by email. Once an invalid application has been rejected, the whole application must be re-submitted.</p>

<p>All documents should be submitted in PDF format with one PDF file for each document. PDF files must be readable and it must be possible to ‘cut and paste’ data from them.</p>

<p>All leaflets should be submitted in a single, combined PDF document.</p>

<h2>Documents for submission</h2>

<p>To make a <abbr title="parallel import">PLPI</abbr> submission you need to complete the application form, including details of the appropriate UK cross-reference product which the application is based on.</p>

<p>The following documents should be sent to <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> along with the application form:</p>

<ul>
  <li>proof of payment form – even if there is no fee for your application</li>
  <li>completed <span class="attachment-inline"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/391639/label_summary_template.doc">label summary template</a> (<span class="type">MS Word Document</span>, <span class="file-size">42 KB</span>)</span> – this cover sheet is required when submitting any labels (whether initials or variations)</li>
  <li>mock-ups of all proposed labelling and the patient information leaflet (PIL) in English</li>
  <li>user testing report (if applicable)</li>
  <li>the relevant complete sample with the foreign leaflet intact</li>
  <li>an updated company functions list (assembler, batch release, storage, importer and distributor) (if applicable)</li>
</ul>

<p><a class="govuk-link" href="https://www.gov.uk/guidance/make-a-payment-to-mhra">Make a payment to <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr></a></p>

<h3>2 strikes and out initiative</h3>

<p>If there is information missing from your submission or changes need to be made, we will write to you twice (<span class="attachment-inline"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/391640/guidance_on_requests_for_further_information.pdf">guidance on requests for further information</a> (<span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">4.06 MB</span>, <span class="page-length" lang="en">3 pages</span>)</span>).</p>

<p>If you don’t send the information asked for or make the necessary changes in the timeframe set out in the letter, we will decide whether to refuse the application.</p>

<p>A third and final letter will be sent before the application is refused.</p>

<p>In some cases, <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> will make an exception, for example when the leaflet for the product is undergoing user testing. This will be decided on a case-by-case basis and only in exceptional circumstances.</p>

<h2>Make a variation to your parallel import licence</h2>

<p>You should submit a variation application to <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> if changes are made to the product which you are importing. You can do this using the <a class="govuk-link" href="https://www.gov.uk/guidance/mhra-portal-register-to-submit-forms"><abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> portal</a>. You should also submit a scan of the full product.</p>

<p>When the patient information leaflet for the UK cross-referred product has been updated (excluding certain administrative changes), the <abbr title="parallel import">PLPI</abbr> patient information leaflet will also have to be varied.</p>

<p>If there are any changes to the arrangements for re-packaging the product you need to submit a variation.
You may be charged a fee for the variation.</p>

<p>If you are submitting a variation and have discussed the fee with the <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> <abbr title="parallel import">PLPI</abbr> assessment unit you should include confirmation of this agreement in your application. The <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> <abbr title="parallel import">PLPI</abbr> unit can give you this in the form of an email or letter.</p>

<p>If you are submitting a high volume of submissions, (in excess of 50 variations at the same time) please inform <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> at least 3 days before the submission by emailing <a class="govuk-link" href="mailto:PLPI_submissions@mhra.gov.uk">PLPI_submissions@mhra.gov.uk</a>.</p>

<h3>Tell and do (<abbr title="tell and do">TaD</abbr>) variations</h3>

<p><abbr title="tell and do">TaD</abbr> is a procedure which allows you to submit a variation for a change to the imported product and then carrying on repackaging and distributing the product while <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> assesses the variation.</p>

<p>The incoming product must have been linked with the cross-referred UK product via a mutual recognition or decentralised procedure.</p>

<p>You can only submit <abbr title="tell and do">TaD</abbr> variations following a probation period and when you have written confirmation from <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>.</p>

<p>You will be charged the usual fee for a variation.</p>

<p>It may not be appropriate to submit variations as a <abbr title="tell and do">TaD</abbr> if there are other variations to the same product that are not TaDs.</p>

<p>Variations using <abbr title="tell and do">TaD</abbr> can only be made for the following changes:</p>

<ul>
  <li>name/address of the marketing authorisation holder in the source country</li>
  <li>manufacturer name/site</li>
  <li>excipients</li>
  <li>description/appearance of dosage form</li>
  <li>storage conditions</li>
</ul>

<p>You cannot use a <abbr title="tell and do">TaD</abbr> variation to change the imported marketing authorisation number.</p>

<h3>Make a <abbr title="tell and do">TaD</abbr> variation</h3>

<p>To make a <abbr title="tell and do">TaD</abbr> variation you need to check if the imported product is a MR/DC product. The list is updated often.
See <span class="attachment-inline"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1098827/PI_MR-DC_List_20220815.pdf">MR-DC product list</a> (<span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">2.07 MB</span>, <span class="page-length" lang="en">62 pages</span>)</span> 31 December 2021.</p>

<p>Find the marketing authorisation number of the imported product and then make sure the UK MA number on the list is identical to the cross-referred UK licence on your licence. If your <abbr title="parallel import">PLPI</abbr> licence is cross-referred to a different UK licence you cannot do a <abbr title="tell and do">TaD</abbr>.</p>

<p>Submit your variation adding the following statement in the reason box on the variation application form ‘<abbr title="tell and do">TaD</abbr> – update xxxx’ and complete the variation part of the application form.</p>

<p>You can then make the changes to the PIL and labels and continue repackaging and releasing the product.</p>

<h2>Renew your parallel import licence</h2>

<p>A <abbr title="parallel import">PLPI</abbr> is granted for 5 years.</p>

<p>You can’t make any updates to your licence through a renewal.</p>

<p>Renewals must be submitted in the 3 months before the licence expires.</p>

<p>You should renew your <abbr title="parallel import">PLPI</abbr> licence using the <a class="govuk-link" href="https://www.gov.uk/guidance/mhra-portal-register-to-submit-forms"><abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> Portal</a>.</p>

<h2>Inspections of parallel import companies</h2>

<p><abbr title="parallel import">PLPI</abbr> assessors may accompany inspectors on <a class="govuk-link" href="https://www.gov.uk/guidance/good-manufacturing-practice-and-good-distribution-practice">good manufacturing practice (<abbr title="good manufacturing practice">GMP</abbr>)</a> inspections of <abbr title="parallel import">PLPI</abbr> companies to look particularly at regulatory compliance.</p>

<p>The inspection will:</p>

<ul>
  <li>check the implementation of leaflet safety updates</li>
  <li>check leaflets to see if they are up to date, user tested and incorporated into packs within the correct timescale</li>
  <li>check labels to ensure the correct label is being used and is affixed in the approved manner and that it contains the correct child warning</li>
  <li>check Braille</li>
  <li>check manufacturer details</li>
</ul>

<h2>Fees</h2>

<p><a class="govuk-link" href="https://www.gov.uk/government/publications/mhra-fees/current-mhra-fees#licence-applications-parallel-imports-fees">Fees for <abbr title="parallel import">PLPI</abbr> applications and variations</a></p>

<p><a class="govuk-link" href="https://www.gov.uk/guidance/make-a-payment-to-mhra">Make a payment to <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr></a></p>

<h2>Contact</h2>

<p>For portal issues email <a class="govuk-link" href="mailto:Portal.Manager@MHRA.gov.uk">Portal.Manager@<abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr>.gov.uk</a> or call 020 3080 7100.</p>

<p>If you have a question about the validation of your submission email <a class="govuk-link" href="mailto:RIS.PLPI@mhra.gov.uk">RIS.<abbr title="parallel import">PLPI</abbr>@mhra.gov.uk</a></p>

<p>For information about the progress of your application email <a class="govuk-link" href="mailto:ris.plpi@mhra.gov.uk">ris.plpi@mhra.gov.uk</a> or call 020 3080 7400.</p>

<p>For more general enquiries about PLPIs email <abbr title="Medicines and Healthcare products Regulatory Agency">MHRA</abbr> Customer Services at MHRACustomerServices@mhra.gov.uk or call 020 3080 6000.</p>

</div>

</div>

      <div class="responsive-bottom-margin">
        
<div class="app-c-published-dates app-c-published-dates--history govuk-!-margin-bottom-3" data-module="gem-toggle" lang="en">
    Published 21 January 2015
    <br>Last updated 17 August 2022
      <a class="app-c-published-dates__toggle govuk-link" data-controls="full-history" data-expanded="false" data-toggled-text="-&nbsp;hide all updates" href="#full-history">+&nbsp;show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden">
        <ol class="app-c-published-dates__list">
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2022-08-17T15:58:46.000+01:00">17 August 2022</time>
              <p class="app-c-published-dates__change-note">Updated MR-DC product list.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-12-31T17:56:31.000+00:00">31 December 2021</time>
              <p class="app-c-published-dates__change-note">MR-DC product list updated.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-03-01T15:52:16.000+00:00">1 March 2021</time>
              <p class="app-c-published-dates__change-note">Updated Mutual Recognition/Decentralised product list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-12T15:18:28.000+00:00">12 January 2021</time>
              <p class="app-c-published-dates__change-note">Updated following the end of the transition period. Primarily new information on how to submit your parallel import licence application.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-11-12T10:51:36.000+00:00">12 November 2020</time>
              <p class="app-c-published-dates__change-note">Updated parallel import MR-DC list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-06-03T12:25:52.000+01:00">3 June 2020</time>
              <p class="app-c-published-dates__change-note">Updated MR-DC product list PDF</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-02-28T15:52:56.000+00:00">28 February 2020</time>
              <p class="app-c-published-dates__change-note">Updated MR-DC product list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2019-12-11T09:00:20.000+00:00">11 December 2019</time>
              <p class="app-c-published-dates__change-note">updated the MR-DC product list to 10 December 2019 version</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2019-06-11T16:19:31.000+01:00">11 June 2019</time>
              <p class="app-c-published-dates__change-note">Updated the guidance on user testing information leaflets for parallel imported licences</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2019-05-31T11:52:30.000+01:00">31 May 2019</time>
              <p class="app-c-published-dates__change-note">Updated MR-DC product list to dated 31/05/2019 version</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2018-02-22T14:30:04.000+00:00">22 February 2018</time>
              <p class="app-c-published-dates__change-note">Updated the current MR-DC product list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2017-10-09T16:04:36.000+01:00">9 October 2017</time>
              <p class="app-c-published-dates__change-note">MR-DC product list updated.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2017-09-18T15:24:53.000+01:00">18 September 2017</time>
              <p class="app-c-published-dates__change-note">New MR-DC Product List added to the page.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2017-05-25T16:02:07.000+01:00">25 May 2017</time>
              <p class="app-c-published-dates__change-note">Updated the MR-DC product list.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2017-02-13T09:47:33.000+00:00">13 February 2017</time>
              <p class="app-c-published-dates__change-note">Updated MR/DC list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-12-16T10:20:12.000+00:00">16 December 2016</time>
              <p class="app-c-published-dates__change-note">MR-DC product list updated.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-08-24T12:58:27.000+01:00">24 August 2016</time>
              <p class="app-c-published-dates__change-note">Updated MR-DC product list added - 24/08/2016</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-07-21T12:03:13.000+01:00">21 July 2016</time>
              <p class="app-c-published-dates__change-note">Updated product list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-05-26T12:47:17.000+01:00">26 May 2016</time>
              <p class="app-c-published-dates__change-note">Updated Parallel Import MR-DC List.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-04-28T11:07:01.000+01:00">28 April 2016</time>
              <p class="app-c-published-dates__change-note">Updated Parallel Import MR-DC List.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-03-09T15:27:05.000+00:00">9 March 2016</time>
              <p class="app-c-published-dates__change-note">Updated the current MR-DC product list for parallel import licence.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2016-02-01T11:09:29.000+00:00">1 February 2016</time>
              <p class="app-c-published-dates__change-note">Updated parallel import MR-DC list.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2015-12-23T11:52:58.000+00:00">23 December 2015</time>
              <p class="app-c-published-dates__change-note">Updated parallel import list added</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2015-07-20T15:32:42.000+01:00">20 July 2015</time>
              <p class="app-c-published-dates__change-note">Updated MR-DC product list</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2015-04-10T14:34:28.000+01:00">10 April 2015</time>
              <p class="app-c-published-dates__change-note">MR-DC product list has been updated - 07 April 2015</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2015-02-02T10:36:23.000+00:00">2 February 2015</time>
              <p class="app-c-published-dates__change-note">The most recent MR-DC list has been added to the page.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2015-01-21T13:48:00.000+00:00">21 January 2015</time>
              <p class="app-c-published-dates__change-note">First published.</p>
            </li>
        </ol>
      </div>
</div>

<div class="govuk-!-display-none-print govuk-!-margin-bottom-0" data-module="gem-track-click">
  <form action="/email/subscriptions/single-page/new" class="gem-c-single-page-notification-button" data-button-location="bottom" data-track-action="Subscribe-button-bottom" data-track-category="Single-page-notification-button" data-track-label="/guidance/medicines-apply-for-a-parallel-import-licence" method="POST">
    <input name="base_path" type="hidden" value="/guidance/medicines-apply-for-a-parallel-import-licence">
    <button class="govuk-body-s gem-c-single-page-notification-button__submit" type="submit">  <svg class="gem-c-single-page-notification-button__icon" height="18" viewBox="0 0 459.334 459.334" width="18" xmlns="http://www.w3.org/2000/svg"><path d="M177.216 404.514c-.001.12-.009.239-.009.359 0 30.078 24.383 54.461 54.461 54.461s54.461-24.383 54.461-54.461c0-.12-.008-.239-.009-.359H175.216zM403.549 336.438l-49.015-72.002v-89.83c0-60.581-43.144-111.079-100.381-122.459V24.485C254.152 10.963 243.19 0 229.667 0s-24.485 10.963-24.485 24.485v27.663c-57.237 11.381-100.381 61.879-100.381 122.459v89.83l-49.015 72.002a24.76 24.76 0 0 0 20.468 38.693H383.08a24.761 24.761 0 0 0 20.469-38.694z" fill="currentColor"></path></svg>Get emails about this page
</button>
</form>
</div>

      </div>

      <div class="app-c-contents-list-with-body__link-wrapper" data-sticky-element="">
        <div class="app-c-contents-list-with-body__link-container">
          <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

        </div>
      </div>
  </div>
    
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>

  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer" data-track-count="footerRelatedItemSection">Explore the topic</h2>

  <ul class="gem-c-related-navigation__link-list" data-module="gem-track-click">


        <li class="gem-c-related-navigation__link"><a class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic" data-track-category="relatedLinkClicked" data-track-label="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing" data-track-options="{&quot;dimension28&quot;:&quot;1&quot;,&quot;dimension29&quot;:&quot;Marketing authorisations, variations and licensing guidance&quot;}" href="/topic/medicines-medical-devices-blood/marketing-authorisations-variations-licensing">Marketing authorisations, variations and licensing guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>